“acceleron-pharma” Archives

in
Entry Author Date Location
Celgene Files for FDA Approval of Blood Disease Drug 04/05/19 New York
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups   07/27/18 National
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More 07/13/18 National
Acceleron, Celgene Drug Shines in Phase 3 Test in Rare Blood Disorder 07/09/18 Boston
15 For ’18: Key Clinical Data to Watch For Next Year (Part 1) 12/04/17 National
With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug 08/01/17 Boston
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs 10/17/16 New York
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
Verastem Sinks as Mesothelioma Study Halted For Futility 09/28/15 Boston
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
East Coast Biotech Roundup: Celgene, Blueprint(s), Intarcia & More 05/01/15 Boston
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech 04/29/15 New York
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More 04/13/15 Boston
Flagship Ventures Raises Sails for $537M Fund, Its Largest to Date 03/26/15 Boston
Investors Line up For Westphal as Muscle Cramp Startup Upsizes IPO 01/28/15 Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Polaris Partners Adds $450M for Seventh Fund 11/24/14 Boston
To Fight Cramps, Christoph Westphal Taps Boston All-Stars for $40M 09/09/14 Boston
East Coast Biotech Roundup: Acceleron, Seres, Sage, & More 07/18/14 Boston
How a Little Serendipity Led Acceleron to a Crippling Blood Disease 07/17/14 Boston
Lightstone Closes $172M Fund for Early-Stage Biotechs 05/01/14 Boston
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More 02/28/14 Boston
East Coast Life Sciences Roundup: NY Genome Center, Acceleron, Bind, & More 09/20/13 Boston
Acceleron Prices Upsized IPO at $15 Per Share, Begins Trading Thursday 09/19/13 Boston
East Coast Life Sciences Roundup: KiiLN, Celgene, Acceleron, & More 08/09/13 New York
Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M 08/07/13 Boston
Page 1 of 3 next page »